| Application no. and date | 17885750.4 (espacenet) (Federated) (European Patent Register), 20171229 | | Patent/reg. no. and date | DK/EP 3562486, 20240313 | | Publication date | 20191106 | | Priority no. and date | US 201662441164 P, 20161231, US 201762471393 P, 20170315, US 201762542323 P, 20170808 | | EP pub. no. and date |
EP 3562486 20191106 | | Effective date | | | Applicant/owner | BioXcel Therapeutics, Inc., 555 Long Wharf Drive, 5th Floor
New Haven, CT 06511, US | | Applicant ref. no. | 1696407 | | Inventor | NANDABALAN, Krishnan, c/o Bioxcel Therapeutics, Inc.
780 East Main Street
Branford, Connecticut 06405, US,
YOCCA, Frank, c/o Bioxcel Therapeutics, Inc.
780 East Main Street
Branford, Connecticut 06405, US,
SHARMA, Sameer, c/o Bioxcel Therapeutics, Inc.
780 East Main Street
Branford, Connecticut 06405, US | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 31/415 (2006.01) , A61K 31/4174 (2006.01) , A61K 45/06 (2006.01) , A61K 47/10 (2017.01) , A61K 9/00 (2006.01) , A61K 9/20 (2006.01) , A61P 25/00 (2006.01) | | Title | ANVENDELSE AF SUBLINGUAL DEXMEDETOMIDIN TIL BEHANDLING AF AGITATION | | Int. application no. | US2017069030 | | Int. publication no. | WO2018126182 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
